Literature DB >> 12539178

Angiogenesis in pituitary adenomas.

Shozo Yamada1, Kouji Takada.   

Abstract

Angiogenesis, which is the formation of new blood vessels from preexisting capillaries, plays an important role in tumor growth and metastasis. In this review, the focus is on angiogenesis in pituitary adenomas. Angiogenesis of pituitary adenomas has been assessed by studying tumor microvessel density using specific immunohistochemical markers to clarify the relationship between angiogenesis and tumor behavior. Unlike other organs, pituitary adenomas have significantly lower vascular densities as compared to nontumorous adenohypophysis, suggesting that the lack of significant angiogenesis may play a role in the slow pace of pituitary tumor growth and rarity of metastases. In addition, the relationship between microvessel density and various factors in pituitary adenomas is reviewed, including tumor types, age and sex, invasiveness, malignancy, several proliferative markers (MIB-1 or Ki-67). However, further studies will be needed, since many studies have reached opposite conclusions. Angiogenesis is a complex multistep process and several factors are found to be involved in each step of neovascularization, such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and various other cytokines. VEGF and bFGF (or FGF-2), which are the most potent angiogenesis inducers among them, have been studied by immunohistochemistry, in situ hybridization, or in vitro studies in normal or adenomatous pituitaries and these results are also discussed in this review. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12539178     DOI: 10.1002/jemt.10262

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  14 in total

1.  Vascularization of rat pituitary autografts.

Authors:  Matilde Lombardero; Andres Quintanar-Stephano; Sergio Vidal; Eva Horvath; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  J Anat       Date:  2006-05       Impact factor: 2.610

2.  Endocan, a new invasion and angiogenesis marker of pituitary adenomas.

Authors:  Fumihiro Matano; Daizo Yoshida; Yudo Ishii; Shigeyuki Tahara; Akira Teramoto; Akio Morita
Journal:  J Neurooncol       Date:  2014-02-07       Impact factor: 4.130

3.  Radiological apoplexy and its correlation with acute clinical presentation, angiogenesis and tumor microvascular density in pituitary adenomas.

Authors:  Jung-Sup Lee; Yong-Sook Park; Jeong-Taik Kwon; Taek-Kyun Nam; Tae-Jin Lee; Jae-Kyun Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

4.  Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in pituitary adenomas.

Authors:  Kyongsong Kim; Daizo Yoshida; Akira Teramoto
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

5.  Expression of hypoxia-inducible factor 1alpha and cathepsin D in pituitary adenomas.

Authors:  Daizo Yoshida; Kyongsong Kim; Michio Yamazaki; Akira Teramoto
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

6.  Vascular endothelial growth factor (VEGF), prostaglandin E2(PGE2) and active renin in hypertension of adrenal origin.

Authors:  S Zacharieva; I Atanassova; M Orbetzova; G Kirilov; E Nachev; K Kalinov; R Shigarminova
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

7.  The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.

Authors:  D Yoshida; K Koketshu; R Nomura; A Teramoto
Journal:  J Neurooncol       Date:  2010-03-23       Impact factor: 4.130

8.  Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach.

Authors:  N Sandow; W Klene; U Elbelt; C J Strasburger; P Vajkoczy
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

9.  Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia.

Authors:  Ryutaro Nomura; Daizo Yoshida; Akira Teramoto
Journal:  J Neurooncol       Date:  2009-03-12       Impact factor: 4.130

10.  Study of the telomerase hTERT fraction, PCNA and CD34 expression on pituitary adenomas. Association with clinical and demographic characteristics.

Authors:  Alma Ortiz-Plata; Martha Lilia Tena Suck; Mario López-Gómez; Alfonso Heras; Aurora Sánchez García
Journal:  J Neurooncol       Date:  2007-03-15       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.